ALPHATEC HOLDINGS, INC. Research and Development Expense
ALPHATEC HOLDINGS, INC. (ATEC) reported Research and Development Expense of $17.77 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-03-15
- ALPHATEC HOLDINGS, INC. research and development expense for the quarter ending 2014-06-30 was $4.53M, a 23.68% increase year-over-year.
- ALPHATEC HOLDINGS, INC. research and development expense for the quarter ending 2014-03-31 was $4.18M, a 13.55% increase year-over-year.
- ALPHATEC HOLDINGS, INC. research and development expense for the quarter ending 2013-12-31 was $3.81M, a 1.78% decline year-over-year.
- ALPHATEC HOLDINGS, INC. research and development expense for the quarter ending 2013-09-30 was $3.03M, a 5.85% decline year-over-year.
- ALPHATEC HOLDINGS, INC. research and development expense for fiscal 2015 was $17.77M, a 5.76% increase from fiscal 2014.
- ALPHATEC HOLDINGS, INC. research and development expense for fiscal 2014 was $16.80M, a 18.39% increase from fiscal 2013.
- ALPHATEC HOLDINGS, INC. research and development expense for fiscal 2013 was $14.19M, a 4.68% decline from fiscal 2012.
- ALPHATEC HOLDINGS, INC. research and development expense for fiscal 2012 was $14.89M, a 11.85% decline from fiscal 2011.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2015-12-31 | $17.77M 10-K · filed 2016-03-15 | |||
| 2014-12-31 | $16.80M 10-K · filed 2016-03-15 | |||
| 2014-06-30 | $4.53M 10-Q · filed 2014-07-31 | $8.71M 10-Q · filed 2014-07-31 | $12.53M derived: sum of 3 quarters · filed 2016-03-15 | $15.56M derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | $4.18M 10-Q · filed 2014-05-01 | $8.00M derived: sum of 2 quarters · filed 2016-03-15 | $11.02M derived: sum of 3 quarters · filed 2016-03-15 | $14.69M derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $6.84M derived: sum of 2 quarters · filed 2016-03-15 | $10.51M derived: sum of 3 quarters · filed 2016-03-15 | $14.19M 10-K · filed 2016-03-15 |
| 2013-09-30 | $3.03M 10-Q · filed 2013-11-12 | $6.69M derived: sum of 2 quarters · filed 2014-07-31 | $10.38M 10-Q · filed 2013-11-12 | $14.26M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $3.67M 10-Q · filed 2014-07-31 | $7.35M 10-Q · filed 2014-07-31 | $11.23M derived: sum of 3 quarters · filed 2015-02-27 | $14.45M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $3.68M 10-Q · filed 2014-05-01 | $7.57M derived: sum of 2 quarters · filed 2015-02-27 | $10.78M derived: sum of 3 quarters · filed 2015-02-27 | $14.56M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $7.10M derived: sum of 2 quarters · filed 2015-02-27 | $10.88M derived: sum of 3 quarters · filed 2015-02-27 | $14.89M 10-K · filed 2015-02-27 |
| 2012-09-30 | $3.22M 10-Q · filed 2013-11-12 | $6.99M derived: sum of 2 quarters · filed 2013-11-12 | $11.00M 10-Q · filed 2013-11-12 | $14.24M derived: sum of 4 quarters · filed 2014-03-20 |
| 2012-06-30 | $3.78M 10-Q · filed 2013-08-07 | $7.79M 10-Q · filed 2013-08-07 | $11.02M derived: sum of 3 quarters · filed 2014-03-20 | $14.88M derived: sum of 4 quarters · filed 2014-03-20 |
| 2012-03-31 | $4.01M 10-Q · filed 2013-05-02 | $7.25M derived: sum of 2 quarters · filed 2014-03-20 | $11.10M derived: sum of 3 quarters · filed 2014-03-20 | $15.48M derived: sum of 4 quarters · filed 2014-03-20 |
| 2011-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $7.09M derived: sum of 2 quarters · filed 2014-03-20 | $11.47M derived: sum of 3 quarters · filed 2014-03-20 | $16.89M 10-K · filed 2014-03-20 |
| 2011-09-30 | $3.86M 10-Q · filed 2012-11-06 | $8.24M derived: sum of 2 quarters · filed 2012-11-06 | $13.65M 10-Q · filed 2012-11-06 | $17.74M derived: sum of 4 quarters · filed 2013-03-05 |
| 2011-06-30 | $4.38M 10-Q · filed 2012-08-08 | $9.79M 10-Q · filed 2012-08-08 | $13.88M derived: sum of 3 quarters · filed 2013-03-05 | $17.63M derived: sum of 4 quarters · filed 2013-03-05 |
| 2011-03-31 | $5.41M 10-Q · filed 2012-05-08 | $9.50M derived: sum of 2 quarters · filed 2013-03-05 | $13.25M derived: sum of 3 quarters · filed 2013-03-05 | $18.16M derived: sum of 4 quarters · filed 2013-03-05 |
| 2010-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05 | $7.83M derived: sum of 2 quarters · filed 2013-03-05 | $12.74M derived: sum of 3 quarters · filed 2013-03-05 | $16.43M 10-K · filed 2013-03-05 |
| 2010-09-30 | $3.75M 10-Q · filed 2011-11-04 | $8.66M derived: sum of 2 quarters · filed 2011-11-04 | $12.35M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | $4.91M 10-Q · filed 2011-08-08 | $8.60M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $13.49M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |